drugset / Trial / NCT00619073
PACT (Platelet Activity After Clopidogrel Termination)
Completed
15 enrolled
University of Massachusetts, Worcester
Bristol-Myers Squibb · collabSanofi · collab
RandomizedCrossoverQuadruple-blindBasic science
Summary
Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots. The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting risk. However, this theory has never been rigorously tested. The goal of this research is to determine whether discontinuation of clopidogrel results in increased platelet function.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Comparator | Aspirin | Small molecule | 81 mg | Oral |